Related Experiment Video
Updated: Jan 27, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.
Kumar Prabhash1, Suresh H Advani2, Ullas Batra3
1Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, Maharashtra, India. kprabhash1@gmail.com.
This guideline offers Indian oncologists a practical reference for molecular biomarker testing in non-small cell lung cancer (NSCLC). It addresses challenges and provides recommendations for accurate biomarker identification to improve patient care.
Area of Science:
- Oncology
- Molecular Pathology
- Genomics
Background:
- Advanced non-small cell lung cancer (NSCLC) diagnosis has been transformed by molecular targets and targeted therapies.
- Implementing molecular screening for predictive biomarkers in India faces operational and logistical hurdles.
- A consensus guideline is needed to facilitate biomarker testing in Indian clinical settings.
Purpose of the Study:
- To establish a consensus guideline for biomarker testing in NSCLC for Indian medical oncologists, molecular pathologists, and pathologists.
- To provide a competent reference addressing the challenges of molecular screening in India.
- To support informed decision-making for improved NSCLC patient care.
Main Methods:
- Consensus development involving Indian medical oncologists, molecular pathologists, and pathologists.
- Summarization of key targetable mutations (e.g., EGFR, ALK, ROS1) and biomarkers (e.g., PD-L1) in NSCLC.
- Review of diagnostic tests including immunohistochemistry, FISH, PCR, and NGS, with pros and cons.
- Inclusion of pre-analytical procedure considerations and quality assessment checklists.
Main Results:
- The guideline details important targetable mutations and biomarkers for NSCLC.
- It critically evaluates various diagnostic testing modalities.
- An algorithm for diagnostic decision-making and a laboratory quality checklist are provided.
Conclusions:
- This guideline serves as a crucial reference for biomarker testing in NSCLC in India.
- It aims to overcome implementation challenges and standardize molecular strategies.
- The recommendations will aid healthcare professionals in making informed choices for better NSCLC management.
Related Concept Videos
Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
Legal Guidelines for Documentation
Guidelines for Sketching a Curve
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Lung Capacity

